Potential clinical application of interleukin-27 as an antitumor agent. - Wikidata - wikimedia - TriplyDB

Potential clinical application of interleukin-27 as an antitumor agent.

Potential clinical application of interleukin-27 as an antitumor agent.

http://www.wikidata.org/entity/Q34483131

about

Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family Circulating low IL-23: IL-35 cytokine ratio promotes progression associated with poor prognosisin breast cancer An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.Dual Roles of IL-27 in Cancer Biology and Immunotherapy.Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.LYG1 exerts antitumor function through promoting the activation, proliferation, and function of CD4+ T cells.Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.Role of interleukin-32 in cancer biology.IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy.Polycationic carbosilane dendrimer decreases angiogenesis and tumor-associated macrophages in tumor-bearing mice

P2860

Q28075849-47694EAF-B6A0-4132-8380-B1135E36A092 Q36964158-700823D1-2D42-4649-830C-6DD275424CD9 Q38749945-28DB981C-F2FB-493D-8953-7ADCE360A8C1 Q39158943-2DAADB3B-8C6D-4693-9428-DCF36CD270EC Q48018788-B2BCABE4-7309-4F0C-9BD8-BD92A84E63F7 Q50642148-282F7029-D82F-4C74-8DD0-6087F4D761A2 Q51279715-E4E8A5F1-8E72-4EF8-A5F8-F1A3C2E51254 Q53725899-D0C79860-35E0-4C32-A413-77F2E19728D5 Q55264916-1ADFE8A7-B12D-4DCB-BD47-188A0961AA4E Q55300547-EF4431D7-6C95-4094-AFBC-519B83A1D3C3 Q57079914-C773554F-FFD9-49F4-BA75-39710ED32860

P2860

Potential clinical application of interleukin-27 as an antitumor agent.

http://www.wikidata.org/entity/Q34483131

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Potential clinical application of interleukin-27 as an antitumor agent.

@ast

Potential clinical application of interleukin-27 as an antitumor agent.

@en

Potential clinical application of interleukin-27 as an antitumor agent.

@nl

type

label

Potential clinical application of interleukin-27 as an antitumor agent.

@ast

Potential clinical application of interleukin-27 as an antitumor agent.

@en

Potential clinical application of interleukin-27 as an antitumor agent.

@nl

prefLabel

Potential clinical application of interleukin-27 as an antitumor agent.

@ast

Potential clinical application of interleukin-27 as an antitumor agent.

@en

Potential clinical application of interleukin-27 as an antitumor agent.

@nl

P1433

Q34483131-6EEFEDFE-1E12-458E-9C1B-798DBBAA9788

P1476

Q34483131-CE3780B9-9C38-4A26-9360-5941DCC211AA

P2093

Q34483131-05765D2F-8DF9-475E-810A-E511B9FF753F

Q34483131-3F726332-74CB-440A-B9E2-B5C05152C5AD

Q34483131-5F3C4F9A-7EEB-4A9E-887B-20A49159FC83

Q34483131-7ACF6C78-DED3-45F7-80A0-8D6233E94400

Q34483131-D8D103F4-EC51-45FF-9EC8-268C772B769C

Q34483131-E4B452A5-FE68-4B94-A739-2FED6C1E2A4F

Q34483131-E8750504-6D37-4A57-8ADD-7F4755ED9DF7

P275

Q34483131-C63A1127-559A-4900-B224-EF60627D6B25

P2860

Q34483131-0527B3F1-20EF-43AB-8654-181B6F3ABD40

Q34483131-07F43975-AC73-45E8-9DA1-B6CFE2C942CF

Q34483131-125B4DAA-CD2C-4682-A849-661667DA6C4A

Q34483131-133E99D3-67D2-458E-B7CE-AFE770BD6D29

Q34483131-13A835EA-453D-47D0-9DD3-1956C9A8FEF0

Q34483131-18409FED-A8F6-479C-8E24-E8DF08DA67A6

Q34483131-1AC0B404-93A4-40D8-A62D-123C4861F305

Q34483131-1C1BE8E6-54D2-478D-9DA7-742A1F53EF37

Q34483131-20BAD3F9-2A23-4526-BAE2-B1A5430DF84A

Q34483131-20C4C054-691F-462F-A0A0-CA3FEDA3D911

P304

Q34483131-17588707-F6E1-4AC3-99BF-8FF880321245

P31

Q34483131-89424D97-3340-47AB-93C8-93708388B2FD

Q34483131-FBB39412-2112-48FC-8D3D-A6F51D9E8534

P356

Q34483131-0D2B6267-FF35-40A4-AB57-7FAA26036FA7

P433

Q34483131-3E90EB72-7FC2-417B-8C10-CD10FB0600B8

P478

Q34483131-8D8B52EC-D2AB-4E26-8295-3010FDB71DEC

P5008

Q34483131-F82454A3-59A2-4FB6-B4B7-C69A8E97BCE1

P577

Q34483131-43C481A4-266D-4A24-9D48-B51589133663

Q34483131-D399F04E-6324-4F25-B6FB-505EAF0AF8B0

P5875

Q34483131-ADFF0EF4-C19B-42AF-9FB8-A7618A7568A1

P698

Q34483131-68F82FD2-2E07-44F0-ABAE-8BA233915BBF

P921

Q34483131-B874F7BC-98B2-4788-87A1-AC5015C16B5A

Q34483131-C1867D4E-E26F-42C6-82DC-23B75FE93134

P932

Q34483131-926DEC48-743F-4623-B34D-EF61E1FCCB31

P356

P1433

P1476

Potential clinical application of interleukin-27 as an antitumor agent.

@en

P2093

Izuru Mizoguchi

http://www.w3.org/2001/XMLSchema#string

Jun-Ichi Furusawa

http://www.w3.org/2001/XMLSchema#string

Kaname Higuchi

http://www.w3.org/2001/XMLSchema#string

Mingli Xu

http://www.w3.org/2001/XMLSchema#string

Ren Tsunoda

http://www.w3.org/2001/XMLSchema#string

Takayuki Yoshimoto

http://www.w3.org/2001/XMLSchema#string

Yukino Chiba

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Interleukin-12 and the regulation of innate resistance and adaptive immunity

IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.

Activation of JAK2-V617F by components of heterodimeric cytokine receptors

Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.

IL-10 elicits IFNγ-dependent tumor immune surveillance.

P304

1103-1110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12731

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279731512

http://www.w3.org/2001/XMLSchema#string

P698

26132605

http://www.w3.org/2001/XMLSchema#string

P921

P932

4582978

http://www.w3.org/2001/XMLSchema#string